Name | Number of supported studies | Average coverage | |
---|---|---|---|
CD8-positive, alpha-beta T cell | 4 studies | 16% ± 1% | |
conventional dendritic cell | 3 studies | 18% ± 3% | |
epithelial cell | 3 studies | 28% ± 4% | |
GABAergic neuron | 3 studies | 27% ± 6% | |
glutamatergic neuron | 3 studies | 31% ± 11% | |
transit amplifying cell | 3 studies | 27% ± 8% | |
erythrocyte | 3 studies | 27% ± 14% | |
CD4-positive, alpha-beta T cell | 3 studies | 17% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 20% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 97% | 721.97 | 2560 / 2642 | 99% | 28.69 | 696 / 705 |
lung | 97% | 508.64 | 558 / 578 | 98% | 30.06 | 1137 / 1155 |
breast | 95% | 417.96 | 438 / 459 | 98% | 32.14 | 1098 / 1118 |
intestine | 96% | 575.85 | 923 / 966 | 98% | 40.71 | 516 / 527 |
uterus | 94% | 331.23 | 160 / 170 | 98% | 43.54 | 451 / 459 |
skin | 100% | 2189.39 | 1806 / 1809 | 92% | 31.88 | 436 / 472 |
ovary | 89% | 325.98 | 161 / 180 | 100% | 29.29 | 429 / 430 |
bladder | 90% | 431.29 | 19 / 21 | 98% | 35.19 | 496 / 504 |
esophagus | 84% | 697.62 | 1209 / 1445 | 100% | 48.84 | 183 / 183 |
thymus | 97% | 398.44 | 634 / 653 | 84% | 14.31 | 506 / 605 |
adrenal gland | 97% | 967.61 | 249 / 258 | 84% | 16.18 | 193 / 230 |
prostate | 96% | 404.80 | 236 / 245 | 81% | 11.44 | 405 / 502 |
stomach | 72% | 282.79 | 258 / 359 | 99% | 41.26 | 283 / 286 |
kidney | 91% | 359.37 | 81 / 89 | 74% | 10.97 | 670 / 901 |
pancreas | 34% | 84.79 | 111 / 328 | 89% | 13.92 | 159 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 33.78 | 29 / 29 |
spleen | 100% | 988.83 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 45.81 | 45 / 45 |
liver | 47% | 150.06 | 106 / 226 | 51% | 6.76 | 206 / 406 |
adipose | 96% | 460.12 | 1159 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 89% | 321.62 | 1186 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 83% | 1263.45 | 767 / 929 | 0% | 0 | 0 / 0 |
muscle | 74% | 247.24 | 598 / 803 | 0% | 0 | 0 / 0 |
heart | 70% | 265.75 | 603 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 46% | 4.83 | 37 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006915 | Biological process | apoptotic process |
GO_0000281 | Biological process | mitotic cytokinesis |
GO_0007026 | Biological process | negative regulation of microtubule depolymerization |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0072686 | Cellular component | mitotic spindle |
GO_0005813 | Cellular component | centrosome |
GO_0015630 | Cellular component | microtubule cytoskeleton |
GO_0005874 | Cellular component | microtubule |
GO_0000922 | Cellular component | spindle pole |
GO_0005737 | Cellular component | cytoplasm |
Gene name | CKAP2 |
Protein name | Cytoskeleton-associated protein 2 (CTCL tumor antigen se20-10) (Tumor- and microtubule-associated protein) Cytoskeleton associated protein 2 |
Synonyms | hCG_1743134 TMAP LB1 |
Description | FUNCTION: Possesses microtubule stabilizing properties. Involved in regulating aneuploidy, cell cycling, and cell death in a p53/TP53-dependent manner (By similarity). . |
Accessions | C9J7Y4 ENST00000480747.1 Q8WWK9 B2RMQ4 ENST00000378034.7 [Q8WWK9-4] ENST00000258607.10 [Q8WWK9-5] ENST00000490903.5 [Q8WWK9-6] ENST00000468284.1 C9J649 ENST00000378037.9 [Q8WWK9-1] |